-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
17 Nov 2025
-
Net transactions value
-
-$7,454,252
-
Form type
-
4
-
Filing time
-
18 Nov 2025, 16:36:32 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| BENKOWITZ MICHAEL |
PRESIDENT AND COO |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
18 Nov 2025 |
0001673232 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$1,980,518 |
+14,625 |
|
$135.42 |
14,625 |
17 Nov 2025 |
by Trust |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Sale |
$6,880,091 |
-14,625 |
-100% |
$470.43 |
0 |
17 Nov 2025 |
by Trust |
F1, F2 |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$383,329 |
+2,625 |
|
$146.03 |
2,625 |
17 Nov 2025 |
by Trust |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Options Exercise |
$766,658 |
+5,250 |
+200% |
$146.03 |
7,875 |
17 Nov 2025 |
by Trust |
F1, F3 |
| transaction |
UTHR |
Common Stock |
Sale |
$3,704,665 |
-7,875 |
-100% |
$470.43 |
0 |
17 Nov 2025 |
by Trust |
F1, F3 |
| holding |
UTHR |
Common Stock |
|
|
|
|
|
2,648 |
17 Nov 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
UTHR |
Stock Options |
Options Exercise |
$0 |
-14,625 |
-55% |
$0.000000 |
12,000 |
17 Nov 2025 |
Common Stock |
14,625 |
$135.42 |
by Trust |
F1, F2 |
| transaction |
UTHR |
Stock Options |
Options Exercise |
$0 |
-2,625 |
-100% |
$0.000000 |
0 |
17 Nov 2025 |
Common Stock |
2,625 |
$146.03 |
by Trust |
F1, F3 |
| transaction |
UTHR |
Stock Options |
Options Exercise |
$0 |
-5,250 |
-12% |
$0.000000 |
37,690 |
17 Nov 2025 |
Common Stock |
5,250 |
$146.03 |
by Trust |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: